Please provide your email address to receive an email when new articles are posted on . Patients with intermediate junctional epidermolysis bullosa are at risk for kidney-urinary tract manifestations, ...

Dr Joe Wiley, CEO of Amryt Pharma, commented: “Today’s announcement of the positive data from EASE marks another significant milestone for Amryt as we seek approval for FILSUVEZ®. These results also ...

Please provide your email address to receive an email when new articles are posted on . Patients with epidermolysis bullosa are at risk for delayed puberty, which can have a significant impact on bone ...

A gel derived from birch bark is the first topical medication ever tested in the treatment of epidermolysis bullosa (EB) to heal wounds faster than placebo. The results come from the largest ...

Skin grafts genetically engineered from a patient’s own cells can heal persistent wounds in people with an extremely painful dermatologic disease, a Stanford Medicine-led clinical trial has shown. The ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful dermatologic disease, a Stanford Medicine-led clinical trial has shown. The ...

The financing supports Eliksa’s clinical development of ELK-003, a biological eye drop for ocular complications in Epidermolysis bullosa (EB) patients. The ongoing pilot study in cooperation with ...

A new spray for treating severely painful blisters, mouth ulceration and oral scarring in patients with a rare genetic skin condition is being developed by researchers at the University of Birmingham.

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Epidermolysis Bullosa Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...

NEW YORK, NEW YORK - FEBRUARY 03: Eddie Vedder And The Earthlings perform at theBeacon Theatre on February 03, 2022 in New York City. (Photo by Theo Wargo/Getty Images) Pearl Jam’s frontman turns his ...